1. Home
  2. CLDI

as of 12-04-2025 3:22pm EST

$1.52
+$0.02
+1.33%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Chart Type:
Time Range:
Founded: 2014 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 9.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 217.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -9.02 EPS Growth: N/A
52 Week Low/High: $1.10 - $26.04 Next Earning Date: 11-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered CLDI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 74.71%
74.71%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: